A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer
Abstract About 20 percent of TNM-stage II colon cancer patients who are treated by surgical resection develop recurrence, and adjuvant chemotherapy in this group is still debated among researchers and clinicians. Currently, adverse histopathological and clinical factors are used to select patients f...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2018-04-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-018-24519-4 |